LONDON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionical Emas (“Bionical”) or (“the Company”), the Early Access Programs and Clinical Trial Supply business, is selling its Clinical Development division, ...

Willington, UK, June 19, 2024 – Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, ...

LONDON, UK – 29 May 2025: Bionical Emas, a global provider of Clinical Trial Services, announces an exclusive global clinical trial supply agreement with Pharma Resources GmbH, German pharmaceutical ...

WILLINGTON, England, June 27, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare ...

HILLSBOROUGH, NJ / ACCESSWIRE / May 28, 2017 / Bionical, a partner to the pharmaceutical and biotech industries, is pleased to announce that Andy Woolf, CEO, US has been named to PM360's 2017 Elite ...

SMi Reports: Interview excerpt with Bionical EMAS’ Executive VP, Tom Watson released for SMi’s 9th Annual Conference on Orphan Drugs & Rare Diseases, in London in less than 3 weeks With less than 3 ...

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such ...

WILLINGTON, England and DUBLIN, May 11, 2020 /PRNewswire/ -- Bionical Emas and Jazz Pharmaceuticals (NASDAQ: JAZZ) have entered into an agreement to provide appropriate patients in the United States ...

Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to ...

WILLINGTON, England, June 19, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare ...